Frontier IP PLC (LON:FIPP) said a joint project between it and the University of Cambridge to tackle gum disease has received a £52,891 grant from the National Biofilms Innovation Centre (NBIC).
The proof-of-concept award will support an eight-month project to explore the potential of origami-like DNA nanostructures to disrupt the dental plaque biofilms formed by P.gingivalis, the bacterium responsible for gum disease.
Built around the work of Dr Ioanna Mela, the investigation will also attempt to identify at least one DNA nanostructure to take forward into commercial development in partnership with industry.
In a statement, Frontier IP chief executive Neil Crabb said: "We strongly believe in the benefits of identifying innovative technology at a very early stage to better understand and shape its commercial potential through engagement with the industry partners.
“The funding from the NBIC for this project is a clear validation of Dr Mela's work on DNA nanostructures and its potential to combat the scourge of gum disease."
Frontier is a specialist in developing university research.